774 related articles for article (PubMed ID: 18430126)
1. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
2. Fungal infections in cancer patients: an escalating problem.
Samonis G; Bafaloukos D
In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
[TBL] [Abstract][Full Text] [Related]
3. New aspects of emerging fungal pathogens. A multifaceted challenge.
Schell WA
Clin Lab Med; 1995 Jun; 15(2):365-87. PubMed ID: 7671578
[TBL] [Abstract][Full Text] [Related]
4. Management of immunocompromised patients with evidence of an invasive mycosis.
Walsh TJ
Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563
[TBL] [Abstract][Full Text] [Related]
5. [Scedosporium inflatum, a new pathogenic fungus. Report of 2 cases with a fatal outcome].
Guarro J; Gaztelurrutia L; Marín J; Bárcena J
Enferm Infecc Microbiol Clin; 1991 Nov; 9(9):557-60. PubMed ID: 1822709
[TBL] [Abstract][Full Text] [Related]
6. [Opportunistic systemic mycoses].
Szalka A; Prinz G
Orv Hetil; 1991 Aug; 132(34):1851-6, 1859. PubMed ID: 1881662
[TBL] [Abstract][Full Text] [Related]
7. Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases.
Walsh TJ; Lee JW; Roilides E; Pizzo PA
Curr Opin Oncol; 1992 Aug; 4(4):647-55. PubMed ID: 1511021
[TBL] [Abstract][Full Text] [Related]
8. [Fungal infections in patients with ARC with or without AIDS. Evaluation of the chemosensitivity of the isolated strains].
Michelone G; Cavanna C; Gramegna G; Maccabruni A; Lombardi G
G Ital Chemioter; 1987; 34(1-3):23-7. PubMed ID: 3504411
[No Abstract] [Full Text] [Related]
9. [Testing the sensitivity of opportunistic agents of mycoses to antimycotic drugs in vitro].
Otcenásek M; Buchta V
Cesk Epidemiol Mikrobiol Imunol; 1993 Mar; 42(1):29-34. PubMed ID: 8485769
[TBL] [Abstract][Full Text] [Related]
10. Host-parasite relationship in opportunistic mycoses.
Waldorf AR
Crit Rev Microbiol; 1986; 13(2):133-72. PubMed ID: 3533424
[TBL] [Abstract][Full Text] [Related]
11. Fungal infections.
Kauffman CA
Clin Geriatr Med; 1992 Nov; 8(4):777-91. PubMed ID: 1423134
[TBL] [Abstract][Full Text] [Related]
12. [Lomentospora prolificans Fungemia in a Patient With T-Cell Large Granular Leukemia: A Rare Pathogen in Türkiye].
Kaya EK; Taştekin MB; Arikan Akdağli S; Gülmez D; Topeli A; Uzun Ö
Mikrobiyol Bul; 2024 Apr; 58(2):209-219. PubMed ID: 38676587
[TBL] [Abstract][Full Text] [Related]
13. [Current topics in mycology].
Khan M; Plempel M; Wassilew SW
Z Hautkr; 1989 Oct; 64(10):837-8, 841-2. PubMed ID: 2686240
[TBL] [Abstract][Full Text] [Related]
14. Impact of the changing epidemiology of fungal infections in the 1990s.
Pfaller M; Wenzel R
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):287-91. PubMed ID: 1396747
[TBL] [Abstract][Full Text] [Related]
15. [Fungal infections].
Kahanpää A
Duodecim; 1973; 89(23):1536-51. PubMed ID: 4589024
[No Abstract] [Full Text] [Related]
16. Emerging fungal pathogens.
Anaissie EJ; Bodey GP; Rinaldi MG
Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):323-30. PubMed ID: 2497012
[TBL] [Abstract][Full Text] [Related]
17. The emerging fungal threat.
Sternberg S
Science; 1994 Dec; 266(5191):1632-4. PubMed ID: 7702654
[No Abstract] [Full Text] [Related]
18. Lung infections due to emerging fungal pathogens.
Machiavello Roman FJ; Pischel L; Azar MM
Curr Opin Pulm Med; 2024 May; 30(3):258-265. PubMed ID: 38411158
[TBL] [Abstract][Full Text] [Related]
19. [Antimycotic sensitivity of clinically important yeasts and moulds in the agar diffusion method (author's transl)].
Dermoumi H
Mykosen; 1982 Mar; 25(3):109-17. PubMed ID: 7088025
[No Abstract] [Full Text] [Related]
20. How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.
Denham ST; Wambaugh MA; Brown JCS
J Mol Biol; 2019 Jul; 431(16):2982-3009. PubMed ID: 31078554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]